Search results for "temi"

showing 10 items of 3194 documents

A real-time non-intrusive FPGA-based drowsiness detection system

2011

Automotive has gained several benefits from the Ambient Intelligent researches involving the deployment of sensors and hardware devices into an intelligent environment surrounding people, meeting users’ requirements and anticipating their needs. One of the main topics in automotive is to anticipate driver needs and safety, in terms of preventing critical and dangerous events. Considering the high number of caused accidents, one of the most relevant dangerous events affecting driver and passengers safety is driver’s drowsiness and hypovigilance. This paper presents a low-intrusive, real-time driver’s drowsiness detection system for common vehicles. The proposed system exploits the ‘‘bright p…

Drowsiness detection systemSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniGeneral Computer ScienceComputer sciencebusiness.industryFrame (networking)Real-time computingAutomotive industryProcess (computing)Advanced driver assistance systemsImage processingDriver assistance systemReal-time image and video processingFPGA based prototypingEmbedded systemIntelligent environmentField-programmable gate arraybusinessJournal of Ambient Intelligence and Humanized Computing
researchProduct

Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium

2013

Current malaria therapeutics demands strategies able to selectively deliver drugs to Plasmodium-infected red blood cells (pRBCs) in order to limit the appearance of parasite resistance. Here, the poly(amidoamines) AGMA1 and ISA23 have been explored for the delivery of antimalarial drugs to pRBCs. AGMA1 has antimalarial activity per se as shown by its inhibition of the in vitro growth of Plasmodium falciparum, with an IC50 of 13.7 μM. Fluorescence-assisted cell sorting data and confocal fluorescence microscopy and transmission electron microscopy images indicate that both polymers exhibit preferential binding to and internalization into pRBCs versus RBCs, and subcellular targeting to the par…

Drug3003PlasmodiumPolyamineErythrocytesPrimaquinemedia_common.quotation_subjectmalariaPharmaceutical ScienceAntimalarialPrimaquinePharmacologyParasitemiatargeted drug deliveryAntimalarialsMiceChloroquineparasitic diseasesPolyaminesmedicineAnimalsInternalizationDrug Carriermedia_commonDrug CarriersMice Inbred BALB CbiologyAnimalPlasmodium falciparumChloroquinePoly(amidoamine)polyamidoaminebiology.organism_classificationnanomedicineErythrocyteTargeted drug deliveryFemalepolymer-drug carrierPlasmodium yoeliimedicine.drug
researchProduct

In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.

2007

Predicting the clinical outcome of a systemic mycosis is often a difficult task, especially when microbiological resistance is one of the factors contributing to therapeutic failure. Some of these factors are host-related--e.g. immune state, site and severity of infection, poor compliance to therapy--while others are associated with the drug's characteristics--e.g. dosage, type of compound (fungistatic/fungicidal), pharmacokinetic properties and drug-drug interactions. In the last few years, clinicians have been confronted with the problem of selecting the most appropriate antifungal therapy for systemic infections and have highlighted the need for a reliable method to assay the in vitro su…

DrugAntifungal AgentsSystemic mycosismedia_common.quotation_subjectMicrobial Sensitivity TestsBiologyPharmacologyPeptides Cyclicchemistry.chemical_compoundEchinocandinsLipopeptidesPharmacokineticsCaspofunginDrug Resistance FungalmedicineHumansPharmacology (medical)Fluconazolemedia_commonCandidaPharmacologyVoriconazoleTriazolesYeastIn vitroInfectious DiseasesPyrimidinesOncologychemistryVoriconazoleCaspofunginFluconazolemedicine.drugJournal of chemotherapy (Florence, Italy)
researchProduct

5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Re…

2010

5-Fluorouracil (5-FU) is currently used for treatment of oral squamous cell carcinoma (OSCC). 5-FU is given by i.v. although the systemic administration is associated with severe toxic effects and no topical formulations of 5-FU for buccal drug delivery have been reported. In this study we would report the development of buccal tablets suitable for direct application of low-doses of 5-FU on cancer lesions. The topical administration could be effective on tumor area while systemic undesired side effects are avoided. Preliminarily, the limited tendency of 5-FU to cross the buccal tissue was established using reconstituted human oral epithelium (RHOE, in vitro) and porcine buccal mucosa (ex vi…

DrugAntimetabolites AntineoplasticPathologymedicine.medical_specialtySwineChemistry PharmaceuticalDrug Compounding5-Fluorouracilmedia_common.quotation_subjectPharmaceutical ScienceApoptosisSettore MED/08 - Anatomia PatologicaLocoregional drug deliveryOral Squamous Cell CarcinomaPermeabilityTissue Culture TechniquesDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheCarcinomaAnimalsHumansMedicinemedia_commonbusiness.industryMouth MucosaAdministration BuccalCancerBuccal administrationmedicine.diseaseReconstituted Human Oral Epitheliumstomatognathic diseasesSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFluorouracilDrug deliveryCarcinoma Squamous CellSystemic administrationMouth NeoplasmsFluorouracilPorcine buccal mucosaBuccal tabletsbusinessEx vivoTabletsmedicine.drugCurrent Drug Delivery
researchProduct

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

2010

Abstract Artemisinins are plant products with a wide range of medicinal applications. Most prominently, artesunate is a well tolerated and effective drug for treating malaria, but is also active against several protozoal and schistosomal infections, and additionally exhibits anti-angiogenic, anti-tumorigenic and anti-viral properties. The array of activities of the artemisinins, and the recent emergence of malaria resistance to artesunate, prompted us to synthesize and evaluate several novel artemisinin-like derivatives. Sixteen distinct derivatives were therefore synthesized and the in vitro cytotoxic effects of each were tested with different cell lines. The in vivo anti-angiogenic proper…

DrugArtemisininsSwinemedia_common.quotation_subjectmalariaArtemisia annuaAngiogenesis InhibitorsDrug resistanceArtemisia annuaP-glycoproteinPharmacologychemotherapyStructure-Activity Relationshipchemistry.chemical_compoundIn vivoparasitic diseasesmedicineAnimalscancerArtemisininCells CulturedZebrafishCell Proliferationmedia_commondrug resistancebiologyPlant ExtractsArticlesCell BiologyFlow Cytometrybiology.organism_classificationArtemisininsIn vitrochemistryArtesunateMolecular Medicinemedicine.drugJournal of Cellular and Molecular Medicine
researchProduct

Abstract 5109: Beyond malaria: Second career of artesunate as cancer drug

2017

Abstract More than a decade ago, we initiated a research program on the molecular pharmacology of phytochemicals derived from Chinese medicinal herbs. Bioactive plant extracts have been fractionated by chromatographic techniques. We isolated bioactive compounds and elucidated their chemical structures by nuclear magnetic resonance and mass spectrometry. A promising compounds was artemisinin from Artemisia annua L. and its semisynthetic compound artesunate. Artemisinin and artesunate are anti-malarial drugs. Our data indicated profound activity against cancer cells, but also against various viruses, Schistosoma, Trypanosoma, and even plant crown gall tumors. To elucidate the molecular mode o…

DrugCancer Researchbiologybusiness.industrymedia_common.quotation_subjectArtemisia annuaCancerDrug resistancePharmacologymedicine.diseasebiology.organism_classificationchemistry.chemical_compoundOncologychemistryArtesunatePharmacogenomicsCancer cellMedicineArtemisininbusinessmedia_commonmedicine.drugCancer Research
researchProduct

The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65.

2015

Infection with human cytomegalovirus (HCMV) is a serious medical problem, particularly in immunocompromised individuals and neonates. The success of standard antiviral therapy is hampered by low drug compatibility and induction of viral resistance. A novel strategy is based on the exploitation of cell-directed signaling inhibitors. The broad antiinfective drug artesunate (ART) offers additional therapeutic options such as oral bioavailability and low levels of toxic side-effects. Here, novel ART-derived compounds including dimers and trimers were synthesized showing further improvements over the parental drug. Antiviral activity and mechanistic aspects were determined leading to the followi…

DrugHuman cytomegalovirusTranscriptional Activationmedia_common.quotation_subjectTranscription Factor RelAArtesunateCytomegalovirusPharmacologyCREBAntiviral Agentschemistry.chemical_compoundVirologyDrug Resistance ViralmedicineHumansCyclic AMP Response Element-Binding ProteinHerpesviridaemedia_commonPharmacologybiologyHEK 293 cellsNF-kappa BTranscription Factor RelANF-κBmedicine.diseaseIn vitroArtemisininsUp-RegulationHEK293 CellschemistryMutationbiology.proteinSignal transductionSignal TransductionAntiviral research
researchProduct

In situ delivery of corticosteroids for treatment of oral diseases.

2017

In many mucocutaneous disorders, corticosteroids therapy is currently central. Systemic therapy is restricted to severe disorders whereas topical applications are considered as the first-line treatment. The oral cavity environment, the medication form and other factors related to the delivery method are key factors for the therapy efficiency and effectiveness. Current marketed medications are not able to avoid wrong drug exposure and scarce patients’ compliance. Innovative in situ delivery systems are able to prolong the drug retention time on the mucosa and to avoid the drawbacks of conventional formulations. This review is intended to give a general overview of oral mucocutaneous patholo…

Drugcorticosteroidmedicine.medical_specialtymedia_common.quotation_subjectMucocutaneous zonePharmaceutical ScienceOral cavitySystemic therapy03 medical and health sciences0302 clinical medicineDrug Delivery Systemsin situ deliveryAdrenal Cortex HormonesMedicineHumansoral diseaseIntensive care medicinemedia_commonWrong drugbusiness.industryMouth Mucosa030206 dentistrySurgeryKey factorsSettore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisbusinessMouth DiseasesRetention timeTherapeutic delivery
researchProduct

Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum

2012

Malaria causes millions of death cases per year. Since Plasmodium falciparum rapidly develops drug resistance, it is of high importance to investigate potential drug targets which may lead to novel rational therapy approaches. Here we report on the interaction of translationally controlled tumor protein of P. falciparum (PfTCTP) with the anti-malarial drug artemisinin. Furthermore, we investigated the crystal structure of PfTCTP. Using mass spectrometry, bioinformatic approaches and surface plasmon resonance spectroscopy, we identified novel binding sites of artemisinin which are in direct neighborhood to amino acids 19-46, 108-134 and 140-163. The regions covered by these residues are know…

Drugmedia_common.quotation_subjectPlasmodium falciparumProtozoan ProteinsDrug resistanceBiologyCrystallography X-RayBiochemistryAntimalarialsparasitic diseasesTranslationally-controlled tumor proteinBiomarkers TumormedicineHumansComputer SimulationBinding siteArtemisininmedia_commonPharmacologychemistry.chemical_classificationBinding SitesMolecular StructureTumor Protein Translationally-Controlled 1Plasmodium falciparumSurface Plasmon Resonancebiology.organism_classificationArtemisininsRecombinant ProteinsAmino acidMolecular Docking SimulationchemistryBiochemistryFunction (biology)Protein Bindingmedicine.drugBiochemical Pharmacology
researchProduct

Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin

2013

Artemisinin is a drug, widely used in malaria treatment. As the binding affinity of artemisinin and its derivatives dihydroartemisinin and artesunate to blood serum proteins might influence the effectiveness of the drug, binding of artemisinin and derivatives to serum albumin was studied under near physiological conditions. Binding kinetics indicate a simple, single-step association process for all artemisinin derivatives. The determined changes in enthalpy and entropy upon drug binding clearly indicate that hydrophobic forces are most important for artemisinin and dihydroartemisinin binding, whereas binding of artesunate is governed by both hydrophilic and hydrophobic forces. Key residues,…

Drugmedia_common.quotation_subjectmedicine.medical_treatmentSerum albuminArtesunatePharmaceutical ScienceDihydroartemisininPharmacologyHydrophobic effectchemistry.chemical_compoundBlood serumparasitic diseasesDrug DiscoverymedicineAnimalsArtemisininSerum Albuminmedia_commonPharmacologybiologyChemistryArtemisininsReceptor–ligand kineticsMalariaComplementary and alternative medicineBiochemistryArtesunatebiology.proteinMolecular MedicineCattleDrug Therapy CombinationHydrophobic and Hydrophilic InteractionsProtein Bindingmedicine.drugPhytomedicine
researchProduct